|
(b)(4).Fisher & paykel healthcare (f&p) has requested for the complaint device to be returned for evaluation.F&p will provide a follow up report upon completion of f&p's investigation.Product background: the airvo 3 humidifier (airvo 3) is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.This includes patients who have had upper airways bypassed.The flow may be from 2 - 70 l/min depending on the patient interface.The airvo 3 is for patients in hospitals and subacute facilities.The airvo 3 is not intended for life support.The airvo 3 can deliver these high flow gases through nasal cannula to augment the breathing of spontaneously breathing neonate, infant, child, adolescent and adult patients suffering from respiratory distress and/or hypoxemia in the hospital setting.The airvo 3 is not intended to provide total ventilatory requirements of the patient and is not for use during field transport.
|
|
(b)(4).Corrected data: d9, g3, g6, h2, h3, h6.Product background: the airvo 3 humidifier (airvo 3) is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.This includes patients who have had upper airways bypassed.The flow may be from 2 - 70 l/min depending on the patient interface.The airvo 3 is for patients in hospitals and subacute facilities.The airvo 3 is not intended for life support.The airvo 3 can deliver these high flow gases through nasal cannula to augment the breathing of spontaneously breathing neonate, infant, child, adolescent and adult patients suffering from respiratory distress and/or hypoxemia in the hospital setting.The airvo 3 is not intended to provide total ventilatory requirements of the patient and is not for use during field transport.Method: the subject airvo 3 was received at fisher & paykel healthcare (f&p) in new zealand where it was inspected by a trained f&p investigation engineer.The device was performance tested and the audible alarm function was checked.F&p's investigation is based on the information obtained from the healthcare facility, f&p's evaluation of the subject device, previous investigations of similar complaints, and f&p's knowledge of the product.Results: during testing it was found that the airvo 3 did not have an audible alarm.It was identified that the issue was due to a faulty speaker.The subject speaker was disassembled and visually inspected, no physical damage to the speaker was observed.The speaker is a supplied component that is assembled into the airvo 3.There was no patient involvement reported by the healthcare facility.Conclusion: f&p's investigation was unable to determine the exact cause of the reported event.Based on the information provided by the healthcare facility, f&p's investigation, and knowledge of the product, a possible cause of the speaker fault was due to the speaker component being out of specification.The airvo 3 will generate a visual alarm in the presence of an inaudible alarm.The alarm in the reported event prevents the operation of the subject device and alerts the user to take appropriate and timely action.There was no reported patient involvement reported by the healthcare facility.The user instructions which accompany the airvo 3 provide guidance on troubleshooting alarms generated by the device.The airvo 3 will generate a visual alarm in the presence of an inaudible alarm.The alarm in the reported event prevents the user from operating the device, as therapy cannot be started.The user instructions which accompany the airvo 3 provide guidance on troubleshooting alarms generated by the device.The user instructions state the following: - device fault (fault x.X.X): "a technical fault has occurred, and the patient may need prompt attention.Restart the device to clear the fault condition.If the issue persists, contact your service representative." the user instructions also state: - "make sure the auditory alarm signal is audible to the operator who will respond to alarms by following the instructions in section 7.5 to test the alarm before starting therapy." - "do not use the airvo 3 if it fails [the 7.5 checking the alarm system] test.Contact your fisher & paykel healthcare representative." - "the airvo 3 is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.This includes patients who have had upper airway bypassed." - "the airvo 3 is not intended to provide total ventilatory requirements of the patient and is not for use during field transport." - "the airvo 3 is not intended for life support.Do not use airvo 3 on patients who cannot tolerate a brief interruption of therapy." - "appropriate patient monitoring is required for all patients using the airvo 3.".
|